This fits with previous reports of decreased LZTS1 expression in multiple other tumor types e.g., lung, breast, prostate and kidney carcinomas [15, 23, 30–32, 40], in which LZTS1 levels were negatively correlated with tumor progression [24]. The gene discussed is LZTS1; the disease is neoplasm.